Tempest Therapeutics, Inc.TPSTNASDAQ

Revenue (LTM)

Net Income (LTM)

$-42M

-41.9% YoY

Free Cash Flow

$-33M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.0B)

Unprofitable

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Revenue	0	0	0	0	0
Gross Profit	-1	0	0	0	-0
Operating Income	-19	-27↓39.8%	-35↓28.4%	-29↑15.8%	-42↓44.1%
Net Income	-19	-28↓48.0%	-36↓26.2%	-29↑17.4%	-42↓41.9%
EBITDA	-18	-27↓44.9%	-33↓25.5%	-28↑17.3%	-40↓45.1%
EPS Diluted	-612.56	-7.80↑98.7%	-3.18↑59.2%	-1.91↑39.9%	-1.50↑21.5%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Cash & Equivalents	19	52↑175.4%	31↓39.7%	39↑25.6%	30↓22.8%
Total Current Assets	20	69↑247.9%	33↓52.2%	40↑22.5%	31↓22.0%
Total Assets	23	73↑220.3%	46↓37.1%	52↑12.0%	41↓19.6%
Total Current Liabilities	3	20↑521.5%	7↓63.7%	9↑29.3%	14↑51.1%
Total Liabilities	92	37↓59.5%	28↓24.6%	25↓11.2%	22↓10.0%
Total Equity	-69	36↑152.5%	18↓49.9%	27↑47.8%	19↓28.5%
Total Debt	2	19↑660.0%	22↑19.3%	21↓6.6%	15↓25.6%
Net Debt	-16	-33↓103.2%	-9↑72.6%	-19↓103.7%	-15↑19.7%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-19	-26↓36.5%	-31↓19.7%	-27↑12.0%	-33↓20.7%
Capital Expenditure	-0	-0↓170.0%	-1↓316.3%	-0↑69.8%	-0↓155.9%
Free Cash Flow	-19	-26↓36.8%	-32↓21.2%	-28↑13.0%	-33↓21.6%
Stock-Based Comp	0	1↑143.9%	2↑41.3%	3↑63.1%	5↑108.3%
Net Change in Cash	16	33↑111.9%	-20↓161.3%	8↑139.9%	-9↓211.0%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance